Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. (Q53584686)
Jump to navigation
Jump to search
scientific article published in December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. |
scientific article published in December 2006 |
Statements
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. (English)
Samuel Waxman
1 reference
Yongkui Jing
Duo Chen
Rosemarie Chan
1 December 2006
66
23
11416-11423